Skip to main content
Clinical Trials/CTRI/2024/07/071003
CTRI/2024/07/071003Not yet recruitingNot Applicable

Effects of virtual reality training on muscle mass and balance parameters among elderly sarcopenic individuals with fall risk

sharmila s2 sites in 1 country42 target enrollmentStarted: July 31, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
42
Locations
2
Primary Endpoint
bio impedance analyzer, EMG, Spring hand held dynamometer.

Study Overview

Brief Summary

There is reduction in muscle mass in sarcopenic patients results in reduction in the muscle strength and balance levels which in turn makes the elderly population to loss their balance and led to fall This may result in the limitation of patient’s independence and their long-term immobilization, which can predispose them to various complications and clinical pathologies. Still now there are of studies done in evaluating resistance training in sarcopenic subjects using high velocity tools but there are very limited evidences on evaluating balance and resistance training using virtual reality device.  Hence the purpose of the study is to focus on improving the appendicular skeletal muscle mass and balance in sarcopenic subjects using the new virtual reality technique which is shown to be effective in few studies.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc

Eligibility Criteria

Ages
65.00 Year(s) to 75.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1 Older people with age group of 65 and above 2 SARC –F screening tool greater than 4 points (specificity: 0.90, sensitivity 0.21) 3 A muscle mass of lesser than 7.0 kg/m2 for men and 5.0 kg/m2 for women estimated using bio -impedance analysis, Hand grip strength lesser than 26 kg for men and 18 kg for women 4 Usual gait speed of lesser than 0.8m/sec 5 Not engaging in an exercise program or receiving exercise guidance.

Exclusion Criteria

  • 1 History of deep venous thrombosis and/or blood clotting disorders 2 Those who had significant cardiopulmonary diseases and received oxygen supplementation.
  • 3 Uncontrollable hypertension 4 Experienced a recent infection, or were diagnosed with other diseases and prohibited to participate in sports exercise according to the guidelines of the American College of Sports Medicine will be excluded.
  • 5 Patients who could not walk even with the use of assistive devices will be excluded from this study.

Outcomes

Primary Outcomes

bio impedance analyzer, EMG, Spring hand held dynamometer.

Time Frame: 1st week, 6th week, 12th week

Secondary Outcomes

  • berg balance scale, gait speed, time up and go test.(1st week, 6th week and 12th week.)

Investigators

Sponsor
sharmila s
Sponsor Class
Other [self ]
Responsible Party
Principal Investigator
Principal Investigator

SHARMILA S

vels institute of science and technology

Study Sites (2)

Loading locations...

Similar Trials